Cargando…
Bio-Orthogonal Mediated Nucleic Acid Transfection of Cells via Cell Surface Engineering
[Image: see text] The efficient delivery of foreign nucleic acids (transfection) into cells is a critical tool for fundamental biomedical research and a pillar of several biotechnology industries. There are currently three main strategies for transfection including reagent, instrument, and viral bas...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445537/ https://www.ncbi.nlm.nih.gov/pubmed/28573212 http://dx.doi.org/10.1021/acscentsci.7b00132 |
_version_ | 1783238914781216768 |
---|---|
author | O’Brien, Paul J. Elahipanah, Sina Rogozhnikov, Dmitry Yousaf, Muhammad N. |
author_facet | O’Brien, Paul J. Elahipanah, Sina Rogozhnikov, Dmitry Yousaf, Muhammad N. |
author_sort | O’Brien, Paul J. |
collection | PubMed |
description | [Image: see text] The efficient delivery of foreign nucleic acids (transfection) into cells is a critical tool for fundamental biomedical research and a pillar of several biotechnology industries. There are currently three main strategies for transfection including reagent, instrument, and viral based methods. Each technology has significantly advanced cell transfection; however, reagent based methods have captured the majority of the transfection market due to their relatively low cost and ease of use. This general method relies on the efficient packaging of a reagent with nucleic acids to form a stable complex that is subsequently associated and delivered to cells via nonspecific electrostatic targeting. Reagent transfection methods generally use various polyamine cationic type molecules to condense with negatively charged nucleic acids into a highly positively charged complex, which is subsequently delivered to negatively charged cells in culture for association, internalization, release, and expression. Although this appears to be a straightforward procedure, there are several major issues including toxicity, low efficiency, sorting of viable transfected from nontransfected cells, and limited scope of transfectable cell types. Herein, we report a new strategy (SnapFect) for nucleic acid transfection to cells that does not rely on electrostatic interactions but instead uses an integrated approach combining bio-orthogonal liposome fusion, click chemistry, and cell surface engineering. We show that a target cell population is rapidly and efficiently engineered to present a bio-orthogonal functional group on its cell surface through nanoparticle liposome delivery and fusion. A complementary bio-orthogonal nucleic acid complex is then formed and delivered to which chemoselective click chemistry induced transfection occurs to the primed cell. This new strategy requires minimal time, steps, and reagents and leads to superior transfection results for a broad range of cell types. Moreover the transfection is efficient with high cell viability and does not require a postsorting step to separate transfected from nontransfected cells in the cell population. We also show for the first time a precision transfection strategy where a single cell type in a coculture is target transfected via bio-orthogonal click chemistry. |
format | Online Article Text |
id | pubmed-5445537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-54455372017-06-01 Bio-Orthogonal Mediated Nucleic Acid Transfection of Cells via Cell Surface Engineering O’Brien, Paul J. Elahipanah, Sina Rogozhnikov, Dmitry Yousaf, Muhammad N. ACS Cent Sci [Image: see text] The efficient delivery of foreign nucleic acids (transfection) into cells is a critical tool for fundamental biomedical research and a pillar of several biotechnology industries. There are currently three main strategies for transfection including reagent, instrument, and viral based methods. Each technology has significantly advanced cell transfection; however, reagent based methods have captured the majority of the transfection market due to their relatively low cost and ease of use. This general method relies on the efficient packaging of a reagent with nucleic acids to form a stable complex that is subsequently associated and delivered to cells via nonspecific electrostatic targeting. Reagent transfection methods generally use various polyamine cationic type molecules to condense with negatively charged nucleic acids into a highly positively charged complex, which is subsequently delivered to negatively charged cells in culture for association, internalization, release, and expression. Although this appears to be a straightforward procedure, there are several major issues including toxicity, low efficiency, sorting of viable transfected from nontransfected cells, and limited scope of transfectable cell types. Herein, we report a new strategy (SnapFect) for nucleic acid transfection to cells that does not rely on electrostatic interactions but instead uses an integrated approach combining bio-orthogonal liposome fusion, click chemistry, and cell surface engineering. We show that a target cell population is rapidly and efficiently engineered to present a bio-orthogonal functional group on its cell surface through nanoparticle liposome delivery and fusion. A complementary bio-orthogonal nucleic acid complex is then formed and delivered to which chemoselective click chemistry induced transfection occurs to the primed cell. This new strategy requires minimal time, steps, and reagents and leads to superior transfection results for a broad range of cell types. Moreover the transfection is efficient with high cell viability and does not require a postsorting step to separate transfected from nontransfected cells in the cell population. We also show for the first time a precision transfection strategy where a single cell type in a coculture is target transfected via bio-orthogonal click chemistry. American Chemical Society 2017-05-15 2017-05-24 /pmc/articles/PMC5445537/ /pubmed/28573212 http://dx.doi.org/10.1021/acscentsci.7b00132 Text en Copyright © 2017 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | O’Brien, Paul J. Elahipanah, Sina Rogozhnikov, Dmitry Yousaf, Muhammad N. Bio-Orthogonal Mediated Nucleic Acid Transfection of Cells via Cell Surface Engineering |
title | Bio-Orthogonal Mediated Nucleic Acid Transfection
of Cells via Cell Surface Engineering |
title_full | Bio-Orthogonal Mediated Nucleic Acid Transfection
of Cells via Cell Surface Engineering |
title_fullStr | Bio-Orthogonal Mediated Nucleic Acid Transfection
of Cells via Cell Surface Engineering |
title_full_unstemmed | Bio-Orthogonal Mediated Nucleic Acid Transfection
of Cells via Cell Surface Engineering |
title_short | Bio-Orthogonal Mediated Nucleic Acid Transfection
of Cells via Cell Surface Engineering |
title_sort | bio-orthogonal mediated nucleic acid transfection
of cells via cell surface engineering |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445537/ https://www.ncbi.nlm.nih.gov/pubmed/28573212 http://dx.doi.org/10.1021/acscentsci.7b00132 |
work_keys_str_mv | AT obrienpaulj bioorthogonalmediatednucleicacidtransfectionofcellsviacellsurfaceengineering AT elahipanahsina bioorthogonalmediatednucleicacidtransfectionofcellsviacellsurfaceengineering AT rogozhnikovdmitry bioorthogonalmediatednucleicacidtransfectionofcellsviacellsurfaceengineering AT yousafmuhammadn bioorthogonalmediatednucleicacidtransfectionofcellsviacellsurfaceengineering |